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We investigated this hypothesis by retrospectively de- 
termining the serostatus of IDU taking part in a cohort 
study in Amsterdam, The Netherlands, from Decem- 
ber 1985, and comparing these data with the available 
seroprevalence estimates in a cohort of homosexual 
men in the same city. The estimates for homosexual 
men are based on a combination of two separate co- 
horts: a hepatitis B vaccine trial cohort (1980-1982) 
and a cohort to study HIV infection (1984-1987) [l]. 
One or more serum samples, taken in 1985 or ear- 
lier, could be located for 57 out of a total of 190 
(30%) IDU who were HIV-antibody-positive at study 
entry. These sera had been collected when testing 
for hepatitis B virus markers and subsequently stored. 
After informed consent had been obtained, the sera 
were tested for HIV-antibodies using a conventional 
enzyme-linked immunosorbent assay (ELISA) and con- 
firmed by Western blot. Annual prevalences were es- 
timated by multiplying seropositive-proportions by a 
factor of 0.33 - the fraction of HIV-positive individu- 
als in the cohort study in 1986 [2]. 
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Fig. 1. Estimated HIV seroprevalences compared between inject- 
ing drug users (IDU) and homosexual men in Amsterdam, The 
Netherlands. A, IDU prevalence; - ,IDU fitted to a Weibull 
function; . -1 . . ', homosexual men fitted to a Weibull function. 
Anti-HIV-2antibody detection by an in vitro production method 
In vitro secretion of anti-HIV-antibodies by peripheral 
blood mononuclear cells (PBMC) has been reported 
to occur during HIV-1 infection [1,2]. HIV-1-specific 
immunoglobulin-secreting cells are detectable [31, and 
HIV-1-specific antibody production has also been ob- 
served using PBMC from infected children, with or 
without PBMC stimulation by pokeweed mitogen 141 
or Epstein Barr virus [5] .  This in vitro phenomenon, 
which persists during the course of HIV-1 infection 
[ 1,2], is considered to be a marker of in, vivo stim- 
ulation of the immune system by HIV-1 antigens [ 3 ] .  
Figure 1 shows the annual prevalence estimates of the 
DU cohort and a Weibull function that was fitted to 
these data. It also shows a fitted function with =tii- 
mates from the cohort of homosexual men. The fit- 
ted IDU curve lags behind the homosexual men curve. 
Taking uncertainties in the estimates into account, 
suggests a somewhat later introduction and spread of 
HIV among D U .  AIDS surveillance data confirm this 
Merence: the first case of AIDS in Amsterdam among 
homosexual men was diagnosed in 1982, while the 
first case among IDU was not diagnosed until 1985, 
by which time 50 cases had already been diagnosed 
among homosexual men. 
Extensive overlap between the two risk groups is 
apparent, since both homosexual prostitution and 
homosexual prívate contacts are cornmon among male 
DU: in our cohort 20% reported a history of male 
prostitution, while 22% reported having had non-pro- 
fessional homosexual contacts [31. Our data indicate 
that HIVwas introduced among IDU after homosexual 
men in Amsterdam. Since there is a considerable over- 
lap between these two risk groups, HW was probably 
introduced by IDU who had homosexual contact, al; 
though spread by IDU infected in other countries can- 
not be ruled out. 
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AIDS caused by HIV-2 infection presents numerous 
clinical and biological similarities to HIV-1 infection: 
We therefore investigated whether PBMC from HIV-2- 
infected patients secrete in vitro HIV-2-specific anti- 
bodies. 
- 
PBMC from four HIV-2-infected pregnant women were 
separated from blood. Immunoglobulins adhering to 
the cell membranes were eliminated by preliminary in- 
cubation. PBMC (5 x 106) were cultured without ni- 
togen or antigen. supernatants were recovered after 6 
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Fig. 1 HIV-2 Western blot of four mother/infant couples (HIV-2- 
seropositive mothers). A, plasma of mother; 6, cellular super- 
natant of mother (day 6); C, plasma of infant; D, cellular super- 
natant of infant (day 6); M, mother; I, infant. 
days of PBMC incubation and examined by Western 
blot for the presence of HIV-2-antibody. 
Supernatants of PBMC from these patients contained 
anti-HIV-2-antibodies specific to glycoproteins (gp105 
and gp36) and protein. This in vitro HIV-2-specific 
antibody secretion was detected in symptomatic and 
asymptomatic individuals. 
We also investigated whether PBMC from infants at 
risk of HIV-2 infection (i.e., with HIV-2-seropositive 
mothers) secreted anti-HIV-2-antibodies. 
PBMC from four infants aged 1-8 months were cul- 
tured for G days and the fluids assayed in HIV-2 and 
HIV-1 Western blot assays. This analysis demonstrated 
that supernatant (Fig. 1, lane D) contained anti-HN-2 
antibodies directed against gp105. 
These data indicate that in vitro anti-HIV-2 secretion 
by PBMC is observed in HIV-2-infected patients. This 
phenomenon distinguishes between HIV-2 antibodies 
passively present via maternal transfer and those ac- 
tively synthetized. The methodology described may be 
considered a new simple approach to HIV-2 paediatric 
diagnbsis. 
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We read with great interest the recent report by 
Nishanian et al. [l] on serum soluble CD8 (sCD8) 
molecules as markers of CD8 T-cell activation in HIV-1 
disease. The authors longitudinally measured sCD8 
levels in a large group of subjects selected from the 
Los Angeles cohort. According to their data, sCD8 lev- 
els appear to increase soon after HIV-1 seroconver- 
sion, and high sCD8 levels predict later falls of circu- 
lating CD4 cells as well as AIDS development. These 
data are in accord with our previous observations that 
sCD8 levels reflect the extent of the activation state 
of the CD8 cell compartment during HIV-1 infection 
[2,31. 
We have performed a similar study which further sup- 
ports the relevance of sCD8 as a prognostic marker 
of subsequent clinical evolution in HIV-1-infected pa- 
tients. We retrospectively investigated the possible pre- 
dictive value of sCD8 on disease progression com- 
pared with CD4 cell number in a group of HIV-l-in- 
fected patients. sCD8 and CD4 data were obtained 
for these patients from blood samples collected si- 
multaneously at the time of first seropositivity detec- 
tion, and at regular intervals (evey 3-6 months) dur- 
ing the subsequent follow-up period. We investigated 
264 blood samples obtained between June 1986 and 
June 1991 from 47 HIV-1-positive patients who met the 
above criteria. Twenty were homosexual men, 24 were 
drug users and three belonged to other risk categories. 
The patients were classified according to the Centers 
for Disease Control (CDC) staging system; at the time 
of follow-up, 27 subjects were asymptomatic (CDC 
